Torheim EA - Search Results

1

Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population.

Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM. Torheim EA, et al. Eur J Immunol. 2009 May;39(5):1280-7. doi: 10.1002/eji.200839002. Eur J Immunol. 2009. PMID: 19384871 Free PMC article.

2

A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties.

Ndhlovu LC, Leal FE, Eccles-James IG, Jha AR, Lanteri M, Norris PJ, Barbour JD, Wachter DJ, Andersson J, Taskén K, Torheim EA, Aandahl EM, Kallas EG, Nixon DF. Ndhlovu LC, et al. Among authors: torheim ea. Eur J Immunol. 2010 Jan;40(1):134-41. doi: 10.1002/eji.200939258. Eur J Immunol. 2010. PMID: 19877008 Free PMC article.

3

An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.

Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D. Pettersen FO, et al. Among authors: torheim ea. J Virol. 2011 Jul;85(13):6557-66. doi: 10.1128/JVI.00073-11. Epub 2011 Apr 13. J Virol. 2011. PMID: 21490090 Free PMC article. Clinical Trial.

4

Design of proteolytically stable RI-anchoring disruptor peptidomimetics for in vivo studies of anchored type I protein kinase A-mediated signalling.

Torheim EA, Jarnaess E, Lygren B, Taskén K. Torheim EA, et al. Biochem J. 2009 Oct 23;424(1):69-78. doi: 10.1042/BJ20090933. Biochem J. 2009. PMID: 19715558

5

The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice.

Singh M, Singh P, Vaira D, Torheim EA, Rahmouni S, Taskén K, Moutschen M. Singh M, et al. Among authors: torheim ea. Eur J Clin Invest. 2014 Feb;44(2):146-52. doi: 10.1111/eci.12200. Epub 2013 Nov 28. Eur J Clin Invest. 2014. PMID: 24283208

6

Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro.

Torheim EA, Yndestad A, Bjerkeli V, Halvorsen B, Aukrust P, Frøland SS. Torheim EA, et al. Clin Exp Immunol. 2005 May;140(2):376-83. doi: 10.1111/j.1365-2249.2005.02770.x. Clin Exp Immunol. 2005. PMID: 15807865 Free PMC article.

7

A Multi-Lumen Glaucoma Stent With Titratable Pressure-Lowering Effect: A Proof of Concept Study.

Sverstad A, Torheim EA, Jørstad ØK. Sverstad A, et al. Among authors: torheim ea. Transl Vis Sci Technol. 2022 Sep 1;11(9):20. doi: 10.1167/tvst.11.9.20. Transl Vis Sci Technol. 2022. PMID: 36149647 Free PMC article.

8

Impact of pictograms on medication adherence: A systematic literature review.

Sletvold H, Sagmo LAB, Torheim EA. Sletvold H, et al. Among authors: torheim ea. Patient Educ Couns. 2020 Jun;103(6):1095-1103. doi: 10.1016/j.pec.2019.12.018. Epub 2019 Dec 31. Patient Educ Couns. 2020. PMID: 31924384 Free article.

9

IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8⁺ T-cell responses.

Dadaglio G, Fayolle C, Oberkampf M, Tang A, Rudilla F, Couillin I, Torheim EA, Rosenbaum P, Leclerc C. Dadaglio G, et al. Among authors: torheim ea. Oncoimmunology. 2020 May 12;9(1):1758606. doi: 10.1080/2162402X.2020.1758606. Oncoimmunology. 2020. PMID: 32923117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page